OTC Markets EXMKT - Delayed Quote USD
Arch Therapeutics, Inc. (ARTH)
0.1608
0.0000
(0.00%)
At close: April 23 at 4:00:00 PM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| ABRAMS MICHAEL S Chief Investment Officer | Purchase | Aug 31, 2023 | 10,292 |
| HICKS LAURENCE M. Director | Purchase | Aug 31, 2023 | -- |
| NORCHI TERRENCE W Chief Executive Officer | Purchase | Aug 31, 2023 | 6,862 |
Related Tickers
MTEM Molecular Templates, Inc.
0.0001
0.00%
BETRF BetterLife Pharma Inc.
0.0680
0.00%
AURX Nuo Therapeutics, Inc.
1.5000
+1.35%
ATHXQ Athersys, Inc.
0.0000
0.00%
MSCLF Satellos Bioscience Inc.
0.5020
0.00%
NYMXF Nymox Pharmaceutical Corporation
0.1178
0.00%
NGENF NervGen Pharma Corp.
2.1300
-0.93%
MAZE Maze Therapeutics, Inc.
9.55
-3.14%
MDNAF Medicenna Therapeutics Corp.
0.7590
-0.78%
ACXP Acurx Pharmaceuticals, Inc.
0.3870
+2.73%